Last reviewed · How we verify
Pneumococcal 13-valent Conjugate Vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Pneumococcal 13-valent Conjugate Vaccine (Pneumococcal 13-valent Conjugate Vaccine) — Emory University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pneumococcal 13-valent Conjugate Vaccine TARGET | Pneumococcal 13-valent Conjugate Vaccine | Emory University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pneumococcal 13-valent Conjugate Vaccine CI watch — RSS
- Pneumococcal 13-valent Conjugate Vaccine CI watch — Atom
- Pneumococcal 13-valent Conjugate Vaccine CI watch — JSON
- Pneumococcal 13-valent Conjugate Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Pneumococcal 13-valent Conjugate Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/pneumococcal-13-valent-conjugate-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab